Fierce Biotech Summit 2024

Machine Learning for Therapeutic Discovery and Development

insitro is creating a new approach for target and drug discovery by integrating multimodal data from human cohorts and cellular models with the power of AI and machine learning. We are uncovering genetic targets to unlock new therapeutic hypotheses for the treatment of complex diseases. We ground our discoveries in human genetics and use both human and cell data to generate orthogonal evidence that can increase the probability of success. These insights provide the starting point for discovering new molecules, which we can either build with our in-house, AI-enabled drug discovery platforms or with partners that allow us to extend our impact. Today, insitro is generating a "pipeline through platform" with a focus on metabolic disease, neurodegeneration and oncology. As we approach the clinic, we also aim to deploy our AI models to run smaller, better powered trials, targeting the patients who can benefit most.